Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1β production in dendritic cells

Journal of Biological Chemistry

Volumn 287, Issue 40, 2012, Pages 33656-33663

  Dwivedi, Ved Prakash ^a   Bhattacharya, Debapriya ^a   Chatterjee, Samit ^a   Prasad, Durbaka Vijay Raghva ^e   Chattopadhyay, Debprasad ^b   Van Kaer, Luc ^c   Bishai, William R ^d   Das, Gobardhan ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^e YOGI VEMANA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSATIVE AGENTS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; IMMUNE RESPONSE; INFECTED CELLS; INNATE IMMUNE RESPONSE; INTERLEUKIN-1; M. TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; SHARP CONTRAST; T CELLS; VACCINE STRAINS;

CYTOLOGY; IMMUNOLOGY; TUBES (COMPONENTS);

CELLS;

BACTERIAL PROTEIN; CD4 ANTIGEN; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; REGION OF DIFFERENCE 1; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; LUNG TUBERCULOSIS; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; IMMUNE SYSTEM; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTES; TH2 CELLS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84866927682     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.375154     Document Type: Article

References (42)

1. WHO (2007) Global Tuberculosis Control Surveillance, Planning, Financing, World Health Organization, Geneva, Switzerland
2. WHO (2004) BCG vaccine. Weekly Epidemiol. Record 79, 27-38
3. Almeida Da Silva, P. E., and Palomino, J. C. (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J. Antimicrob. Chemother. 66, 1417-1430
4. Davies, J. (1996) Origins and evolution of antibiotic resistance. Microbiologia 12, 9-16
5. Gillespie, S. H. (2002) Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 46, 267-274
6. Shah, N. S., Wright, A., Bai, G. H., Barrera, L., Boulahbal, F., Martín-Casabona, N., Drobniewski, F., Gilpin, C., Havelková, M., Lepe, R., Lumb, R., Metchock, B., Portaels, F., Rodrigues, M. F., Rüsch-Gerdes, S., Van Deun, A., Vincent, V., Laserson, K., Wells, C., and Cegielski, J. P. (2007) Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13, 380-387 (Pubitemid 46348124)
7. Velayati, A. A., Farnia, P., Masjedi, M. R., Ibrahim, T. A., Tabarsi, P., Haroun, R. Z., Kuan, H. O., Ghanavi, J., Farnia, P., and Varahram, M. (2009) Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level. Eur. Respir. J. 34, 1202-1203
8. Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., Ziazarifi, A. H., and Hoffner, S. E. (2009) Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136, 420-425
9. Flynn, J. L., and Chan, J. (2001) Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (Pubitemid 32368031)
10. Sweeney, K. A., Dao, D. N., Goldberg, M. F., Hsu, T., Venkataswamy, M. M., Henao-Tamayo, M., Ordway, D., Sellers, R. S., Jain, P., Chen, B., Chen, M., Kim, J., Lukose, R., Chan, J., Orme, I. M., Porcelli, S. A., and Jacobs, W. R., Jr. (2011) A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat. Med. 17, 1261-1268
11. Lienhardt, C., Azzurri, A., Amedei, A., Fielding, K., Sillah, J., Sow, O. Y., Bah, B., Benagiano, M., Diallo, A., Manetti, R., Manneh, K., Gustafson, P., Bennett, S., D'Elios, M. M., McAdam, K., and Del Prete, G. (2002) Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 32, 1605-1613 (Pubitemid 34679148)
12. Cooper, A. M., Solache, A., and Khader, S. A. (2007) Interleukin-12 and tuberculosis: an old story revisited. Curr. Opin. Immunol. 19, 441-447 (Pubitemid 47284862)
13. Trinchieri, G. (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146
14. Hickman, S. P., Chan, J., and Salgame, P. (2002) Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naïve T cell polarization. J. Immunol. 168, 4636-4642 (Pubitemid 34441370)
15. + regulatory T cells. J. Mol. Cell. Biol. 2, 30-36
16. Scott-Browne, J. P., Shafiani, S., Tucker-Heard, G., Ishida-Tsubota, K., Fontenot, J. D., Rudensky, A. Y., Bevan, M. J., and Urdahl, K. B. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204, 2159-2169 (Pubitemid 47360876)
17. Yoshimura, A., Wakabayashi, Y., and Mori, T. (2010) Cellular and molecular basis for the regulation of inflammation by TGF-β. J. Biochem. 147, 781-792
18. Kursar, M., Koch, M., Mittrücker, H. W., Nouailles, G., Bonhagen, K., Kamradt, T., and Kaufmann, S. H. (2007) Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178, 2661-2665 (Pubitemid 46333142)
19. Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K., and Urdahl, K. B. (2010) Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207, 1409-1420
20. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., and Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441, 235-238
21. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., and Weaver, C. T. (2006) Transforming growth factor-βinduces development of the Th17 lineage. Nature 441, 231-234
22. Juffermans, N. P., Florquin, S., Camoglio, L., Verbon, A., Kolk, A. H., Speelman, P., van Deventer, S. J., and van Der Poll, T. (2000) Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182, 902-908
23. Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S. D., Wilson, M. S., Cheever, A., Kugler, D., Hieny, S., Caspar, P., Núñez, G., Schlueter, D., Flavell, R. A., Sutterwala, F. S., and Sher, A. (2010) Caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326-3330
24. Ben-Sasson, S. Z., Hu-Li, J., Quiel, J., Cauchetaux, S., Ratner, M., Shapira, I., Dinarello, C. A., and Paul, W. E. (2009) IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. U.S.A. 106, 7119-7124
25. Fine, P. E. (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345
26. Bhattacharyya, S., Singla, R., Dey, A. B., and Prasad, H. K. (1999) Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect. Immun. 67, 5597-5603 (Pubitemid 29508075)
27. + T cells acts in an autocrine manner to induce Th2 differentiation. Eur. J. Immunol. 32, 1428-1433
28. + T cells. J. Immunol. 187, 5627-5635
29. + T to induce Th2 cell differentiation in vitro and in vivo. Int. Immunol. 19, 535-543
30. Guinn, K. M., Hickey, M. J., Mathur, S. K., Zakel, K. L., Grotzke, J. E., Lewinsohn, D. M., Smith, S., and Sherman, D. R. (2004) Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51, 359-370 (Pubitemid 38142126)
31. Sherman, D. R., Guinn, K. M., Hickey, M. J., Mathur, S. K., Zakel, K. L., and Smith, S. (2004) Mycobacterium tuberculosis H37Rv: delta RD1 is more virulent than M. bovis bacille Calmette-Guerin in long-term murine infection. J. Infect. Dis. 190, 123-126 (Pubitemid 38858412)
32. McLaughlin, B., Chon, J. S., MacGurn, J. A., Carlsson, F., Cheng, T. L., Cox, J. S., and Brown, E. J. (2007) A Mycobacterium ESX-1-secreted virulence factor with unique requirements for export. PLoS Pathog. 3, e105
33. Majlessi, L., Brodin, P., Brosch, R., Rojas, M. J., Khun, H., Huerre, M., Cole, S. T., and Leclerc, C. (2005) Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J. Immunol. 174, 3570-3579 (Pubitemid 40354066)
34. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., and Bloom, B. R. (1993) An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254 (Pubitemid 23344886)
35. Pathak, S. K., Basu, S., Bhattacharyya, A., Pathak, S., Kundu, M., and Basu, J. (2005) Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J. Biol. Chem. 280, 42794-42800 (Pubitemid 43049241)
36. Rook, G. A. (2007) Th2 cytokines in susceptibility to tuberculosis. Curr. Mol. Med. 7, 327-337
37. Potian, J. A., Rafi, W., Bhatt, K., McBride, A., Gause, W. C., and Salgame, P. (2011) Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J. Exp. Med. 208, 1863-1874
38. Wilkinson, R. J., Patel, P., Llewelyn, M., Hirsch, C. S., Pasvol, G., Snounou, G., Davidson, R. N., and Toossi, Z. (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J. Exp. Med. 189, 1863-1874
39. Yamada, H., Mizumo, S., Horai, R., Iwakura, Y., and Sugawara, I. (2000) Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice. Lab. Invest. 80, 759-767 (Pubitemid 30340660)
40. Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M., Ryffel, B., and Quesniaux, V. F. (2007) IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179, 1178-1189
41. Chatterjee, S., Dwivedi, V. P., Singh, Y., Siddiqui, I., Sharma, P., Van Kaer, L., Chattopadhyay, D., and Das, G. (2011). Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner. PLoS Pathog. 7, e1002378
42. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., and Campbell, D. J. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602